Roles of macrophage polarization and macrophage-derived miRNAs in pulmonary fibrosis

A Kishore, M Petrek - Frontiers in immunology, 2021 - frontiersin.org
This mini-review summarizes the current evidence for the role of macrophage activation and
polarization in inflammation and immune response pertinent to interstitial lung disease …

[HTML][HTML] Dysregulation of metabolic pathways in pulmonary fibrosis

R Rajesh, R Atallah, T Bärnthaler - Pharmacology & Therapeutics, 2023 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disorder of unknown origin and
the most common interstitial lung disease. It progresses with the recruitment of fibroblasts …

Recent advancement on development of drug-induced macrophage polarization in control of human diseases

L Wang, Q Lu, W Gao, S Yu - Life sciences, 2021 - Elsevier
Macrophages, an important part of human immune system, possess a high plasticity and
heterogeneity (macrophage polarization) as classically activated macrophages (M1) and …

Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches

E Conte - Pharmacology & Therapeutics, 2022 - Elsevier
Over almost 140 years since their identification, the knowledge about macrophages has
unbelievably evolved. The'big eaters' from being thought of as simple phagocytic cells have …

The role of macrophages in connective tissue disease-associated interstitial lung disease: focusing on molecular mechanisms and potential treatment strategies

CC Tseng, YW Sung, KY Chen, PY Wang… - International Journal of …, 2023 - mdpi.com
Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a severe
manifestation of CTD that leads to significant morbidity and mortality. Clinically, ILD can …

Finding solutions for fibrosis: understanding the innate mechanisms used by super‐regenerator vertebrates to combat scarring

F Durant, JL Whited - Advanced Science, 2021 - Wiley Online Library
Soft tissue fibrosis and cutaneous scarring represent massive clinical burdens to millions of
patients per year and the therapeutic options available are currently quite limited. Despite …

A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective

S Qin, P Tan, J Xie, Y Zhou, J Zhao - Chinese Medicine, 2023 - Springer
Pulmonary fibrosis is a chronic progressive interstitial lung disease caused by a variety of
etiologies. The disease can eventually lead to irreversible damage to the lung tissue …

Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease

T Isshiki, M Vierhout, S Naiel, P Ali… - Biochemical …, 2023 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is the representative phenotype of interstitial lung disease
where severe scarring develops in the lung interstitium. Although antifibrotic treatments are …

Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as …

Z Wu, M Jia, W Zhao, X Huang, X Yang, D Chen… - Journal of …, 2022 - Elsevier
Ethnopharmacological relevance Schisandra chinensis decoction derived from the book of
Waitai Miyao (Tao Wang, Tang dynasty) is often used in the treatment of idiopathic …

[HTML][HTML] Natural variation in macrophage polarization and function impact pneumocyte senescence and susceptibility to fibrosis

EJ Chung, S Kwon, U Shankavaram, AO White… - Aging (Albany …, 2022 - ncbi.nlm.nih.gov
Radiation-induced pulmonary fibrosis (RIPF), a late adverse event of radiation therapy, is
characterized by infiltration of inflammatory cells, progressive loss of alveolar structure …